Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lobello

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|August 13, 1998
Colchicine in chronic hepatitis B: a pilot studyA Floreani, S Lobello, M Brunetto, et al.
Journal of Viral Hepatitis|March 11, 1998
Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoringS Lobello, U Lorenzoni, A Vian, et al.
The American Journal of Gastroenterology|January 5, 2002
Preliminary results of a two-center trial with colchicine for the treatment of chronic hepatitis BA Floreani, G Colloredo, S Lobello, et al.
Infection|November 19, 2011
Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?M Milan, S Boninsegna, L Scribano, et al.
Cancer|May 18, 1999
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosisM Chiaramonte, T Stroffolini, A Vian, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Chronic hepatitis D: a vanishing Disease? An Italian multicenter studyG B Gaeta, T Stroffolini, M Chiaramonte, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|August 13, 1998
Colchicine in chronic hepatitis B: a pilot studyA Floreani, S Lobello, M Brunetto, et al.
Journal of Viral Hepatitis|March 11, 1998
Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoringS Lobello, U Lorenzoni, A Vian, et al.
The American Journal of Gastroenterology|January 5, 2002
Preliminary results of a two-center trial with colchicine for the treatment of chronic hepatitis BA Floreani, G Colloredo, S Lobello, et al.
Infection|November 19, 2011
Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?M Milan, S Boninsegna, L Scribano, et al.
Cancer|May 18, 1999
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosisM Chiaramonte, T Stroffolini, A Vian, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Chronic hepatitis D: a vanishing Disease? An Italian multicenter studyG B Gaeta, T Stroffolini, M Chiaramonte, et al.
Pageof 1